Shareholding17 Aug 2026, 02:26 pm
Dhiren Shah Group Acquires 30.81% Stake in Parmax Pharma
AI Summary
Dhiren Chandulal Shah, Sunil Chinubhai Shah, and Persons Acting in Concert (PACs) have acquired 11,52,450 equity shares of Parmax Pharma Limited, representing 30.81% of the total share capital. This acquisition, made off-market on August 13, 2026, pursuant to a Share Purchase Agreement dated June 08, 2026, increases their total holding to 58.01%. The transaction was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total equity share capital of Parmax Pharma remains at ₹3,74,13,000.
Key Highlights
- Acquirers increased stake by 30.81% to 58.01% in Parmax Pharma.
- Transaction involved 11,52,450 equity shares acquired off-market.
- Disclosure made under SEBI (SAST) Regulations, 2011.
- Acquisition was pursuant to a Share Purchase Agreement dated June 08, 2026.
Price Impact
More from PARMAX